| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.72 | 0.008 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |